# Mortality Reduction After Oral Azithromycin Contingency: Mortality Study

> **NCT03338244** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 66228 (actual)

## Conditions studied

- Childhood Mortality

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03338244
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-20
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 66228 (ACTUAL)
- **Last updated:** 2022-08-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03338244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03338244, "Mortality Reduction After Oral Azithromycin Contingency: Mortality Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03338244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*